title: [Combined mitoxantrone therapy for heavily pretreated metastatic breast cancer].
authors.affiliation: Emergency Division, Gunma University Hospital, Maebashi, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Yokoe
authors.forename: Y
authors.initials: Y
authors.lastname: Iino
authors.forename: H
authors.initials: H
authors.lastname: Aoyagi
authors.forename: M
authors.initials: M
authors.lastname: Maemura
authors.forename: N
authors.initials: N
authors.lastname: Sugamata
authors.forename: Y
authors.initials: Y
authors.lastname: Takai
authors.forename: J
authors.initials: J
authors.lastname: Horiguchi
authors.forename: T
authors.initials: T
authors.lastname: Ishida
authors.forename: Y
authors.initials: Y
authors.lastname: Morishita
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D004317:Doxorubicin / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008875:Middle Aged; D008942:Mitoxantrone / Q000008:administration & dosage*; D016879:Salvage Therapy; D012878:Skin Neoplasms / Q000556:secondary
chemical_list: D015251:Epirubicin; D004317:Doxorubicin; D008942:Mitoxantrone